1. Gu, Yu, Xu, Zi-Jun, Zhou, Jing-Dong, Lin, Jiang, Qian, Jun. 2022. SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. In Clinical epigenetics, 14, 162. doi:10.1186/s13148-022-01373-w. https://pubmed.ncbi.nlm.nih.gov/36461046/
2. Zheng, Peng-Fei, Yin, Rui-Xing, Cao, Xiao-Li, Wei, Bi-Liu, Liu, Chun-Xiao. 2021. SYTL3-SLC22A3 Single-Nucleotide Polymorphisms and Gene-Gene/Environment Interactions on the Risk of Hyperlipidemia. In Frontiers in genetics, 12, 679027. doi:10.3389/fgene.2021.679027. https://pubmed.ncbi.nlm.nih.gov/34367243/
3. Sardar, Debosmita, Cheng, Yi-Ting, Woo, Junsung, Maze, Ian, Deneen, Benjamin. 2023. Induction of astrocytic Slc22a3 regulates sensory processing through histone serotonylation. In Science (New York, N.Y.), 380, eade0027. doi:10.1126/science.ade0027. https://pubmed.ncbi.nlm.nih.gov/37319217/
4. Al-Eitan, Laith N, Almasri, Ayah Y, Alnaamneh, Adan H, Mihyar, Ahmad. 2023. Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients. In PloS one, 18, e0294226. doi:10.1371/journal.pone.0294226. https://pubmed.ncbi.nlm.nih.gov/37948393/
5. Wang, Long, Chen, Juan, Zeng, Ying, Wu, Tangchun, Zhou, Li. 2016. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease. In Arteriosclerosis, thrombosis, and vascular biology, 36, 1989-96. doi:10.1161/ATVBAHA.116.307311. https://pubmed.ncbi.nlm.nih.gov/27417586/
智鼠故事 
